RightAnswer Knowledge Solutions Search Results for 164656-23-9

New Search  |  Search Results (164656-23-9)  |  Index of Example Chemical Results Pages
register now
RightAnswer Knowledge Solutions provides access to hundreds of data sources. Our premier and proprietary sources include fully-researched documents from well-established experts in the chemical and HazMat fields.

A search in our system for this chemical would return results – all in one place -- in the following categories from the listed data sources.
  • Chemical Identification
  • Environmental Hazards
  • First Aid/Medical Treatment
  • Handling/Storage/Shipping/Waste Management
  • Personal Protection
  • Physical Hazards/Corrective Response Actions
  • Physical/Chemical Properties
  • Regulatory/Standards/Labels
  • Report Abstracts and Studies
  • Reproductive Risk
  • Toxicology/Health Hazards/Exposure
Example of Acute Exposure data from MEDITEXT.

RightAnswer Proprietary Data Sources:

HAZARDTEXT™ Documentshelp
MEDITEXT® Documentshelp

All Other Data Sources:

LOLI® Listingshelp
REPROTOX® Documentshelp
RTECS® Registryhelp
TERIS Documentshelp
MSDSonline®help

ChemID External Links:

Other Government Links Searched via RegsKnowledge:

State Environmental Regulationshelp
CFR Regulationshelp

Example Content from MEDITEXT for 164656-23-9:


Please note: this is an extract of information from a larger document. Full document and details are available by subscription.

ACUTE EXPOSURE INFORMATION

  1. USES: Dutasteride is indicated for the treatment of symptomatic benign prostatic hyperplasia (BPH).
  1. PHARMACOLOGY: Dutasteride is a selective inhibitor of both the type 1 and type 2 isoforms of steroid 5-alpha-reductase.
  1. EPIDEMIOLOGY: Overdose is rare.
  1. WITH THERAPEUTIC USE
    1. ADVERSE EFFECTS: COMMON: Impotence, decreased libido, and ejaculation disorders. LESS COMMON: Dizziness and breast disorders.
  1. WITH POISONING/EXPOSURE
    1. TOXICITY: There are no reports of toxicity following acute overdose. In volunteer studies, single doses of up to 40 mg (80 times the therapeutic dose) for 7 days have been administered with no significant effects reported.
© 2011-2025 RightAnswer.com, Inc. and/or its licensors. All rights reserved. No claim to original U.S. Govt. works.